BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.109
+0.069 (3.37%)
May 6, 2026, 1:07 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Provision for Genomic Screening Services | 19.09K | 16.07K | 24.22K | 95.82K | 1.52M | | | | | |
Provision for Genomic Screening Services Growth | 18.79% | -33.65% | -74.72% | -93.68% | 1030.30% | | | | | |
Trading of Industrial Chemicals | 7.41M | 9.49M | 9.75M | 10.83M | 11.85M | | | | | |
Trading of Industrial Chemicals Growth | -22.00% | -2.59% | -10.03% | -8.56% | 5.25% | | | | | |
| 7.42M | 9.51M | 9.77M | 10.93M | 13.36M | | | | | |
| -21.93% | -2.66% | -10.60% | -18.21% | 17.31% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 106.25K | 123.27K | 538.06K | - | - | | | | | |
| -13.80% | -77.09% | - | - | - | | | | | |
| 5.83M | 7.46M | 8.22M | - | - | | | | | |
| -21.81% | -9.32% | - | - | - | | | | | |
| 680.99K | 762.14K | 637.19K | - | - | | | | | |
| -10.65% | 19.61% | - | - | - | | | | | |
| 240.76K | 572.03K | 244.40K | - | - | | | | | |
| -57.91% | 134.05% | - | - | - | | | | | |
| 452.64K | 459.00K | 87.03K | - | - | | | | | |
| -1.39% | 427.43% | - | - | - | | | | | |
| 114.87K | 138.30K | - | - | - | | | | | |
| -16.94% | - | - | - | - | | | | | |
| - | - | 42.07K | - | - | | | | | |
| 7.42M | 9.51M | 9.77M | - | - | | | | | |
| -21.93% | -2.66% | - | - | - | | | | | |
Source: S&P Global Market Intelligence.